Back to Newsroom

Curis Reports Third Quarter 2017 Financial Results

LEXINGTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) — Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, reported today its financial results for the third quarter ended September 30, 2017.